company background image
FRE logo

Fresenius SE KGaA XTRA:FRE Stok Raporu

Son Fiyat

€32.77

Piyasa Değeri

€18.5b

7D

-1.2%

1Y

18.6%

Güncellenmiş

19 Nov, 2024

Veri

Şirket Finansalları +

Fresenius SE & Co. KGaA

XTRA:FRE Stok Raporu

Piyasa değeri: €18.5b

FRE Stoklara Genel Bakış

Fresenius SE & Co. KGaA, bir sağlık hizmetleri şirketi olarak kronik hastalara yönelik ürün ve hizmetler sunmaktadır. Daha fazla detay

Ödüller

Adil değer tahminimizden 63.4% daha düşük bir oranda işlem görüyor

Kazançların yılda 38.96% oranında artması öngörülüyor

Analistler hisse senedi fiyatının 22.2% oranında artacağı konusunda hemfikir

Risk Analizi

Yüksek borç seviyesine sahip


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Biopharma Innovations And Critical Growth Initiatives Propel Earnings And Margin Expansion

Key Takeaways Strategic initiatives focused on productivity and organic growth are expected to enhance operational efficiency and drive margin expansion. Successful biosimilar launches and market access efforts support sustained revenue growth and improved financial flexibility.
View narrative
€39.99
FV
18.1% undervalued intrinsic discount
3.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative
TO
Tokyo
Community Contributor

First comes the pain, then the money.

My main narrative for FRE: What former CEO Mark Schneider blow up to an inefficient giant, will now be cut down by actual CEO Michael Sen and trimmed on efficiency from formally 4 segments FMC (dialyses), Helios (private hospitals), Kabi(Generic & Infusions), Vamed (Projects & Digitalization) only 2 remain: Helios, Kabi, the other will be sold, and the intakes will help to restructure the financial situation under Mark Schneider the Spanish hospitals were acquired, this was a good deal: privat hospital runs well in Spain, because of their good reputation wealthy Latin Americans travel for medical treatments to Spain I focus also on: More equity than debt. Ratio is at 62% (debt/equity).
View narrative
€74.00
FV
55.7% undervalued intrinsic discount
24.16%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 months ago author updated this narrative

Fresenius SE & Co. KGaA Rakipler

Fresenius Medical Care

XTRA:FME

€12.2b

SYNLAB

HMSE:SYAB

€2.5b

Siemens Healthineers

XTRA:SHL

€55.1b

Labcorp Holdings

NYSE:LH

US$19.8b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Fresenius SE KGaA
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı€32.77
52 Haftanın En Yüksek Seviyesi€36.24
52 Haftanın En Düşük Seviyesi€24.32
Beta1.04
11 Aylık Değişim-2.03%
3 Aylık Değişim1.64%
1 Yıllık Değişim18.65%
33 Yıllık Değişim-7.70%
5 Yıllık Değişim-34.04%
Halka arzdan bu yana değişim2,802.59%

Son Haberler & Güncellemeler

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Recent updates

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jul 15
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Jun 12
Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

May 28
At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

May 02
With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Mar 29
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Mar 13
Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

Feb 06
Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Jan 19
A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Jan 03
Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Nov 28
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%

Nov 10
Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%

Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return

Oct 27
Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return

Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital

Jul 25
Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jun 19
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Jun 01
At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Apr 18
Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear

Mar 13
Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear

These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Mar 10
These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?

Feb 23
Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?

Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Feb 08
Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Jan 03
The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Nov 28
These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?

Oct 23
Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?

The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Oct 01
The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Aug 07
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Jul 20
Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital

Jul 02
Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital

Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92

Apr 28
Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92

At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Apr 17
At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year

Apr 02
Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year

Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital

Mar 27
Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital

Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's

Feb 24
Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's

Hissedar Getirileri

FREDE HealthcareDE Pazar
7D-1.2%0.8%-0.2%
1Y18.6%17.2%7.8%

Getiri vs. Endüstri: FRE geçen yıl boyunca % 17.2 oranında getiri sağlayan German Healthcare sektörüyle eşleşti.

Getiri vs Piyasa: FRE geçen yıl % 7.8 oranında getiri sağlayan German Piyasasını aştı.

Fiyat Oynaklığı

Is FRE's price volatile compared to industry and market?
FRE volatility
FRE Average Weekly Movement2.5%
Healthcare Industry Average Movement4.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.1%
10% least volatile stocks in DE Market2.4%

İstikrarlı Hisse Senedi Fiyatı: FRE son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: FRE 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1912177,091Michael Senwww.fresenius.com

Fresenius SE & Co. KGaA, kronik hastalar için ürün ve hizmetler sağlayan bir sağlık hizmetleri şirketidir. Dört segment aracılığıyla faaliyet göstermektedir: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios ve Fresenius Vamed. Fresenius Medical Care segmenti, kronik böbrek yetmezliği olan hastalar için ürün ve hizmetler sunmaktadır.

Fresenius SE & Co. KGaA Temel Bilgiler Özeti

Fresenius SE KGaA'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
FRE temel i̇stati̇sti̇kler
Piyasa değeri€18.46b
Kazançlar(TTM)-€479.00m
Gelir(TTM)€22.81b

0.8x

P/S Oranı

-38.5x

F/K Oranı

FRE aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
FRE gelir tablosu (TTM)
Gelir€22.81b
Gelir Maliyeti€17.48b
Brüt Kâr€5.33b
Diğer Giderler€5.81b
Kazançlar-€479.00m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-0.85
Brüt Marj23.37%
Net Kâr Marjı-2.10%
Borç/Özkaynak Oranı60.9%

FRE uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün